Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
Read transcripts of webcasts and audiocasts
Read transcripts of webcasts and audiocasts
Disclaimer: This is a machine-generated transcript and may contain inaccuracies.
Good morning, everyone, and welcome to Haypp Group Q3 results. My name is Gavin O’Dowd and together with our CFO, Peter Deli, we will take you through today's presentation. Starting on slide three, which is the agenda for today. I will take you through an overview of Haypp and Q3 performance highlights. Peter will take us through the financial and segment performances before handing back to me for progress on our key strategic priority markets and an outlook. I would like to take you to slide five to remind you of some of the key dynamics around our business. We are an online retailer of reduced-risk nicotine products (RRPs) with a strong focus on nicotine pouches, which currently make up over 72% of our volumes. We have multiple storefronts per market, and we operate in five markets in Europe, in the US, and in Saudi Arabia. Almost 90% of our revenue comes from product sales, with sales of Media & Insights to the brand owners accounting for over 10%. While jurisdictional complexity around the sale of nicotine is often a hardship, given our expertise and scale, we also view it as a barrier to entry. We are targeting to approximately double our 2024 revenue by 2028, and increase our 2024 EBIT by 3 to 4x. Moving to slide six. The scale of market growth potential in our existing geographic footprint is determined by the US and the UK. While the UK is a distant second, it has some very favorable long-term dynamics. Continuing on to slide seven, the US and the UK are also the two markets with extremely low online penetration rates, reflecting the early stages of the category life cycle, including the historically limited assortment in the US. Hence, these are two markets to which we have dedicated significant resources in recent quarters, and we will touch on this more throughout our presentation. Moving to our quarterly performance updates. And on slide eight for a moment, this quarter saw each of our segments perform in line with their roles. Core markets delivered 61% EBIT growth, funding our operations in growth markets, which in turn grew 54% in revenue. Moving to slide nine, we are happy to see continued robust growth in nicotine pouches of 33% year-on-year. Despite tougher comparators in the US, growth markets have been a significant contributor, with 63% year-on-year growth and now account for almost half of our NP volume. The strong performance in the growth segment accounted for 74% of the Group NP growth. This momentum is underpinned by the group's investment focus and supports our future growth expectations. Moving to our performance highlights on slide ten. An increase in active consumers continues to be the primary driver of our growth. While the increased share of consumption among existing consumers in our core markets also contributed to the 22% volume growth. Gross margins were up to a record high, generating a gross profit increase of 35%. This consisted of substantial increases in Media & Insights, while product gross margin remained constant, highlighting our commitment to the consumer offer, which in turn further accelerates the flywheel. The investment in building our team, particularly in the US and the UK, is now completed, and G&A is relatively flat versus the prior quarter. We have increased the investment in marketing expenditure to accelerate our new customer inflow. While the window remains open. This led to a reduction in EBIT margins, which we expect to continue for the remainder of this year before trending back towards our 2028 guidance. On slide 11, we show the actual performance of each of these KPIs and their relative change versus prior year; growth in consumers flowed through to orders and volume, which in turn led to our highest ever gross margin rates. I would like to pick out our marketing and expand on it in the next slide. So with that, moving to slide 12 and marketing. During our Q4 2025 results, we shared our timeline for our marketing push in the US, some of which we brought forward into Q2 due to improving market conditions. Just to remind everyone, we are launching marketing activities to accelerate our new customer inflow and accelerate our existing flywheel model beyond the growth rates which we are achieving from our organic positions. This quarter, we achieved the highest new consumer acquisition numbers in the US, with the exception of the period of extreme ZYN shortages in the middle of 2024. The activities covered the full funnel of consumer marketing from upper funnel activities such as programmatic and select social media, generating awareness and presence. It is important to note that a key rationale for this is the reinforcement of our organic positions in search, particularly for brand-related keywords. We continue to evaluate the effectiveness of these campaigns, especially regarding how they are impacting awareness and, hence, the LTVs. And we will focus on the ones which are most effective. The lower funnel focused on AdWords and Google Shopping to augment our SEO for keywords such as brands, where the number one position may be held by the brand site, which doesn't sell directly to the consumers. We capture these consumers. Our data suggests that these consumers would have come back online and found us organically over the coming months anyway. Hence, we are reducing the spending on this area in Q4 and increasing focus on the consumer offer, particularly around new products. In summary, we have taken steps and seen positive results. We will continue to optimize both our marketing and our offer to further accelerate consumer acquisition in our flywheel. With that, I will hand over to Peter.
Thank you, Gavin. Good morning everyone. Moving to slide 13. And as usual, I will start with the consumer-based development. However, before we dive in, I would like to highlight two changes affecting the year-over-year comparison. The discontinuation of vape and HNB products in the UK at the end of 2025, and the closure of the Austrian business at the end of June 2026. Neither of them is material to the group's overall performance. However, it is important to note that if we were to exclude these impacts. Net sales growth would have been close to 31%. And now, let me start with consumers. Because the expansion of our consumer franchise underpins the growth of the model. Moving to slide 14. Group active consumers reached 682,000, up 18.8% year-on-year growth. Active consumers increased by 54.7% to 227,000, driven by the US and UK. The moderation from Q2 reflects the much stronger comparator created by the high consumer intake in late September 2025, as well as an approximately four percentage point drag from the closure of Austria. Core active consumers increased by 6.4% to 155,000, with the vast majority of that coming from NP buyers. Moving to slide 15 and looking at our volume. Performance. Total volume increased by 21.8%, while NP volume grew by 33.1% and represented approximately 72% of group volume growth. NP volume increased by 63.4%, with the US and UK both growing more than 190%. Core NP volume increased by 14% and now represents around 58% of core volume. Traditional volume stabilized, while vape and HNB volume declined by 4.3% due to the UK vape discontinuation. Excluding the UK, volume increased by 32%. The category mix therefore continues to move towards nicotine pouches, supporting the group's long-term growth profile. Slide 13 and financial performance. Let me now turn to the financial performance beginning with net sales and gross profit, before addressing the higher investment level and its effect on adjusted EBIT. Moving on. Slide 17 covers our net sales. Net sales reached 1,221,000,000, an increase of 28.2% as reported and 25.7% at constant currency. The headwind from the Q4 2025 discontinuation of vape and HNB in the UK and the Austria discontinuation at the end of Q2 2026 resulted in a two percentage point headwind for the group's net sales growth. Core net sales increased by 19%, or 15% organically; growth net sales increased by 54% or 53.2%. Organically. Growth was predominantly volume-driven, led by the increase in purchasing consumers and strong US and UK NP volumes. Price and mix were positive on a group level as manufacturer pricing was passed through to consumers, and Media & Insights grew substantially at the segment level. Core benefited from a meaningful price and mix, while growth, price, and mix in aggregate was negative; however, it significantly moderated versus the previous quarter, as NP is the main category driver. Mix had a small negative impact, broadly offset by vape and HNB despite the UK vape discontinuation. Moving to slide 18, gross profit increased by 34.8% to 241 million, ahead of net sales growth, and gross margin increased by one percentage point to a new all-time high of 19.7%. The increase in gross profit was mainly driven by Media & Insights, increasing to 12.2% of group net sales, up 1.1 percentage points year on year. Product gross profit, excluding Media & Insights, increased from 73 million to 93 million, an increase of approximately 20 million, or 26.6%, broadly in line with net sales growth. This is deliberate and reflects our model of scale economics being shared. As we grow, we gain better purchasing terms and more efficient fulfillment. Rather than keep these benefits as margin, we reinvest them in the consumer offer through competitive pricing, a broader range, and better service. A stronger offer attracts more consumers and more volume, which in turn builds further scale. This is the flywheel that drives our growth at segment level. Core gross margin improved to 20.5% from 18.1%. Gross margin declined to 18.1% from 20.8%, reflecting the elevated Q3 2025 comparator. Moving to slide 19 and our overheads, adjusted overheads were 185.5 million, or 15.2% of net sales, compared with 13.2% last year. The year-on-year increase in absolute terms was concentrated in G&A and marketing. While fulfillment continues to show scale benefits compared to last year. The biggest driver for the overhead change versus Q2 2026 is clearly the marketing investment. It increased to 3.2% of net sales from 1% last year, mainly reflecting new initiatives. As Gavin spoke about, we are investing in the US and UK to support acquisition and brand awareness. Going forward, we plan to continuously rebalance investment between marketing and the consumer offer, which then will impact gross margin. We are committed to supporting customer acquisition in a scalable way. G&A was 10.4% of net sales, down from 11.3% in Q2. The quarter benefited from the normal favorable holiday accrual effect during the summer; excluding that effect, sequential absolute spending was broadly flat, breaking the growth trend seen in earlier quarters. Fulfillment was 1.7% of net sales. The cost base increased by 14%, while volume increased by 22%, demonstrating continued operating leverage and a 6% reduction in the fixed fulfillment cost per unit. Moving to slide 20 and adjusted EBIT. Adjusted EBIT was 26.3 million, compared with 33.4 million last year, and adjusted EBIT margin was 2.2%, compared with 3.5%. The bridge is clear. Gross profit increased by 62.2 million. This was offset by 59.7 million of higher overheads, out of which 29 million was invested in marketing. Additional depreciation and amortization added 9.7 million, which pressured the margin. Compression therefore reflects deliberate investment in G&A capabilities and marketing. This is not a problem in gross profit generation. Investment in Saudi Arabia reduced the group adjusted EBIT margin by approximately 35 basis points for the coming quarters. The focus is execution and discipline. Reduce and reallocate marketing investment. Preserve the initiatives that work. Moving to slide 21. Inventory decreased sequentially to 315 million from 368 million at the end of Q2, with levels broadly returning close to normal after the temporary opportunistic stock builds. Net working capital decreased by 269 million, and net working capital turnover improved to 7.2 times. Cash flow from operating activities reached 213 million for the first nine months, supported by 113 million working capital inflow. Net debt decreased sequentially to 96.3 million from 222 million, while net debt to last 12 months adjusted EBITDA declined to 0.4 times. Adjusted EBIT. EBITDA declined to 0.4 times. Cash and cash equivalents were 174 million at quarter end. Net debt at quarter end was entirely attributable to short-term and long-term lease liabilities. With that, let me move to slide 22 and segment performance. Growth. I think in this quarter it is clear to see that the growth markets continue to provide the acceleration. And the expansion opportunity, core, provides a growing, profitable and cash-generative foundation. The quarter showed both sides of the model clearly. On slide 23, you can see the details for the growth segment. While on a group level, the impacts are not material. When we are looking at the growth segment year-over-year performance. It is important to bear in mind the negative impacts in the UK and Austria. As I mentioned earlier, these events resulted in a ten percentage point headwind for consumer-based growth and a 12.3 percentage point headwind for reported net sales growth. Despite these headwinds, we closed a successful quarter. Gross active consumers increased by 54.7% to 227,000. Orders increased by 53.1% to 410,000, and total volume increased by 56.2%. NP volume increased by 63.4% to 10.8 million cans. Net sales increased by 54% to 389 million, with organic growth of 53.2%. Gross profit increased by 34.2% to 70.5 million, while gross margin declined to 18.1% from 20.8%, driven by the higher comparator; EBITDA was -48.4 million, compared with -11.6 million last year. The reduction reflects organizational expansion, US and UK marketing investment, as well as the initial Saudi Arabia investment, which was approximately 4 million. Our priority is to continue pursuing the substantial long-term opportunity in both the US and UK. Moving to slide 24. Our core segment delivered another strong quarter. Active consumers increased by 6.4% to 455,000. Orders increased by 8.4% to 1,042,000, and total volume increased by 9%. Nicotine pouches (NP) volume grew by 14%, while snus volume stabilized. Net sales increased by 19% to 832 million SEK, or 15.7% organically. The increase in order frequency and average order value indicates a higher share of wallet. The positive price mix is driven by the rapid increase in Media & Insights and the manufacturer-led price increases. Gross profit increased by 35.1% to 171 million SEK, and the gross margin improved by 2.5 percentage points to 20.5%, supported by higher Media & Insights, revenue volume growth, and positive price mix. EBITDA increased by 61% to 104 million SEK. SEK, and the EBITDA margin expanded by 3.3 percentage points to a record of 12.5%. Core continues to provide a growing, profitable and cash-generative foundation for the Group's investment in growth markets. With this, I hand back the floor to Gavin to walk us through the strategic priorities.
Thank you, Peter. Moving to slide 26 in the US, I would like to start with how the market conditions are changing and how these changes are positively impacting our business. In addition to the announcement from the FDA regarding enforcement discretion in May, there have also been 39 marketing granted orders for nicotine pouches since then, which is unprecedented. The FDA is considering a revision to the PMTA process to further accelerate product innovation, especially for nicotine pouches. This rapid acceleration of new product launches has already begun, with Haypp launching 68 new SKUs during the quarter, all of which came from established brands. This decision is likely to support market growth rates as both more consumers find suitable NP products to switch to, and more existing dual users switch entirely to nicotine pouches. This more dynamic US environment is becoming analogous to the environment which began in Sweden and Norway approximately six years ago, and is an environment we have deep experience in. A broadening assortment has historically been an accelerator for Haypp, as our operating model enables us to carry a significantly larger range of quality products. Our stores are designed to help consumers navigate the product differences to find the product which is right for them. In addition, we have also improved our subscription, loyalty, and referral programs. While all three are showing strong growth, subscriptions in particular are showing excellent exponential growth. We will continue to develop these products to maximize our consumer growth, and we will remain nimble in our mix of investment in marketing and the consumer offering. The range of activities has led to 91% year-on-year volume growth for the quarter. In a market which is growing by approximately ten percentage points. Moving to the UK in the next slide. Slide 27. Based upon Haypp Group's commissioned market survey, 70% of the current NP users in the UK have entered the category in the past two years. And in line with the previous behavior of new entrants into the NP category across many markets, their initial average daily consumption is currently low, at approximately two pouches per day. However, we expect this to grow in line with prior experience as nicotine pouches (NP) take an ever-increasing share of the consumer's nicotine consumption. We estimate the UK NP market is currently growing by circa 40% per annum. As a reminder, we expect to see the main topics of the Tobacco and Vapes Bill, which received royal assent at the end of April, come into force via multiple pieces of secondary legislation. The first, which restricts the sale of products to consumers over 18 years old and also bans sampling, has come into effect at the end of October. The most relevant piece of legislation for Haypp will relate to marketing restrictions and is expected to come into place at the beginning of June 2027. These and other potential changes are expected to further consolidate our market-leading position and accelerate migration to online. I would also like to draw your attention to some of our key highlights in the UK during the quarter. Our performance is supported by a high level of brand owner support and high demand for both our Media & Insights. We continue to accelerate the new consumer inflow while the current market window remains open; this range of activities has led to strong volume growth of over 90% in the quarter, which is over twice that of the estimated overall market growth. Moving on to slide 28 and legal updates regarding the Swedish litigation, the Supreme Administrative Court denied the appeal regarding Snusbolaget Norden AB's tobacco license. As previously guided, no material, financial, or operational impact is expected on our business. Haypp developed biometric age verification solutions for our lockers in Sweden and implemented them on our smaller sites already. We expect to roll it out to our larger Swedish site later this year. Moving to the US, Haypp Group announced a financial provision to allow for settlement of an alleged violation of local regulations in a US city. We have constructive communication with the authority, and work is ongoing to reach a mutually acceptable settlement. The group has established a $2.5 million provision. Moving to the penultimate slide. Slide 30. In summary, underlying consumer dynamics continue to develop favorably, supported by category growth and favorable regulatory environments. Each of the market segments delivered what was expected of them. Core EBITDA increased 61% year-on-year, and the growth segment sales were up 54% year-on-year. Delivering on Haypp Group strategy, strong group organic growth was achieved with volume increases of 22% and net sales increases of 26% in constant currency versus Q3 2025; group gross profit increased by 35% year-on-year, and we reached a new all-time high gross margin of 19.7%, up one percentage point year-on-year, driven by the demand for our Media & Insights; Haypp Group remains on track to deliver its 2028 revenue and profit targets. And with that in mind, moving to the last slide to recap on these targets: revenue growth of 18% to 25% from 2024 at constant currency and a 5.5% adjusted EBIT margin, plus or minus 150 basis points, subject to the investment opportunities which remain at the time, before handing over to the operator. I would like to thank the team for the great work in recent quarters, which led to the continued strong performance in this quarter. And with that, I will hand over to the operator for questions. Thank you.
If you wish to ask a question, please dial star five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial pound key six on your telephone keypad. The next question comes from Mario Adeshina from Barclays. Please go ahead.
Morning, team. Thanks for taking my question. So just a few from me. First of all, on the marketing cut or reallocation, rather, in Q4. I know you may not be able to give us exact numbers, but could you give us a sense of how significant that reduction will be in Q4, and maybe how we should think about the normalized gross run rate for next year as we approach 2027? And then similarly, when are you expecting to see breakeven again on growth EBITDA margins next year? And then finally, just one on ZYN and the comparison regarding the change in can size. Can you just help us understand how that will hit your volumes and help us frame our thinking around that. In Q4 and going forward. Thank you.
Good morning. Let me take those in reverse order. So if I start off, first of all, with the increased number of pouches in ZYN as it goes through, our primary KPI that we start each report with is cans and it will remain cans irrespective of this change. So as you see more pouches sitting within a can, you will undoubtedly see a lower increase in the number of cans that goes through. However, those products are expected to be sold at a slightly higher price than the 15-pouch cans, so you will see it flow through in the form of higher gross margin and higher growth in revenue on the basis of those products than you would see higher growth in volume. Moving back then to your second question regarding the balancing act between profit and growth. And as we look out towards 2027 and into 2028, we will remain with the same principle. We will continue to prioritize growth so long as we see robust growth potential. And with that growth, we expect that to deliver reasonable economies of scale as it runs through. And we have pretty robust gross margins, as you can see already within our growth markets. So hence, growth itself will be the primary driver when it comes to reaching profitability. And having said that, we will continue to navigate the balance between growth and profit, subject to the growth potential that we continue to see for the future years on this one as well. And then back to your first question, which was the balancing act between marketing and investment in the consumer offer. So we will continue to adapt. I think, when it comes to the overall strategy. If I look at the current quarter of Q4 and perhaps the next couple of quarters as well. From an outside perspective, I think I would view this as the overall profitability within the US is not expected to change materially, but what we will do is continue to balance the shape of where that investment is allocated between how much of it is going directly towards generating awareness for the consumer in the form of marketing versus how much is directed toward the consumer offer, which in itself is very strong at accelerating new customer inflow as well. So we will always continue to refine those two over the coming quarters.
Great. Thank you so much.
Thank you.
The next question comes from Christian Small from Pareto Securities. Please go ahead.
Good morning. Yes. So a couple of questions from my side here as well. So maybe starting off with a provision here. Could you give us any more details on what the alleged violations relate to? Is it flavor product labeling, sales channels, and also which city it involves?
Good morning, Christian. And no, I can't, to be frank, as it is an ongoing case at this point in time. And I am somewhat restricted in what I am able to say about it. What I can say is that I am hoping to get this resolved over the next quarter or so, and I think it will become a lot clearer and make a lot more sense. As regards why I cannot say very much at this point in time. There is a confidentiality restriction on this one.
Yeah. Makes sense. But just wondering here, because you said it will have no direct impact on your future sales in the US. What are you basing that assumption on?
We are in robust, we are in, let's say, rock-solid engagement. And we have very robust, very healthy discussions with the counterpart on this one. So we are feeling reasonably confident with the statement that we have made already.
Perfect. And then, maybe a follow-up on a previous question here regarding marketing reallocation here in Q4. Just wondering which channels or activities you are planning on dropping. And you also refer to helping those that work. And which are these, starting off with that.
Yeah. So I think this was the point I was trying to touch upon on the marketing side as we went through, whereby particularly on the lower funnel marketing, while it was excellent at bringing new customers in, we realized when we did a little more research on this one, many of those new customers were at a stage of maturity and curiosity around the category that even if we got them in a little bit earlier with the marketing activities we were doing in the lower funnel, they would have come to us organically anyway, just a little bit later. So hence, we feel as though we are happy to trim that back at this point in time.
Okay. And how do you think that this will affect customer acquisition in Q4?
So I think we are reasonably confident with our customer acquisition numbers going forward. And part of the reason why we are rebalancing some of the investment into marketing and back towards the consumer offer is to support that. Both of those are there to drive consumer acquisition, and it is the fine-tuning of it within those two to optimize for long-term consumer acquisition. So we don't see this as having a material impact for the future.
Yeah. Perfect. And then maybe lastly on the 39 products approved since May. How many of those are for your US range and how many were already selling? And do you have any sense of how many new products were added here in Q3, and what can we expect to add in Q4 and moving forward?
Yeah. So just to be clear, there are two aspects here. One is 39 new products received a marketing granted order, right? There is also a higher number of new orders. I think there are 68 new SKUs which have actually come to market onto our platform since then. So, some of those products which received a marketing granted order have actually yet to move into production, so I expect those to be coming to market imminently as they go through. And because of the guidance that the FDA provided in May, whereby they were prepared to offer a degree of flexibility, there is a range of new products which have also come to market that are still awaiting the marketing granted orders to come through. So those are two slightly different sets of numbers when looking at it. But from a commercial perspective, I think the 68 new SKUs, which we have launched during the quarter, is the most prominent point as it relates to the regulatory perspective, the sustainability of the category, and the outlook for the category and the FDA's approach to it. I think the 39 marketing granted orders are critical for that point. It is critical to illustrate that point.
Yes, perfect. That is all from me. Thank you so much.
Perfect. Thank you.
The next question comes from Daniel Therrien from Deutsche Bank. Please go ahead.
Hey, Gavin. Thanks for taking the questions. You previously explained that Media & Insights, the improvements in offerings made in 2025, have been a meaningful contributor in 2026. And now, with Media & Insights appearing to be a more important driver of gross margin as you enter the 2027 discussions, are you seeing greater engagement and how much further runway is there to broaden the number or scope of these offerings?
Yeah. Good morning, Daniel. The way we generally develop both our media and, to a great extent, our insights as well is that we develop them during the year. And then while we may test them with a select partner or two toward the latter part of the year to validate that they're working. We then generally engage suppliers in negotiations at this time of the year for the following year, and then roll them out generally from the beginning of January, and it rolls forward. And that is why you will often see a notable uptick from one year to the next, moving from Q4 to Q1 on our Media & Insights as it runs through. And this year is no different versus the last 5 or 6, whereby we do the development during the year, we do the testing in Q3. For beta testing, we do the live testing in Q4, and then we roll out in Q1. So, media and insights continue to grow and are driven by two dimensions, really. Particularly on the media aspect, there are two dimensions: the increased scale of our business means that the existing media is worth more because we are reaching more consumers. And the second dimension is that the products themselves tend to take a step change each year as it goes through, which makes them more valuable as well. That is equally valid for the insights. Insights we can often roll out some aspects of during the year, but it tends to make the biggest notable change as you move from one year to the next. Because we generally run with 12-month calendar-long contracts as it goes through. There are prime examples of this coming through at this point in time. For example, we have recently launched a sensory panel, whereby we have established our own panel to evaluate each of the individual products and what the consumer is experiencing. Within that, we are combining that data with the underlying product testing which we have. But most importantly, we are combining it with the consumer data on how consumers are reacting. And that, for example, is something which will be rolled out now and across our business partners throughout 2027 as an extra driver for insights revenue.
Okay. Makes sense. And then just one more from me. In a statement, you had described subscriptions as scaling rapidly in the US and also promising within core. Could you just give a sense of the scale of that today? And more broadly, as subscriptions become more important, how do you balance the benefits of that greater loyalty and potentially reducing product experimentation, particularly given innovation and new product discovery are important drivers to the long-term category potential?
Yeah. Historically, if you and I were having this conversation 4 or 5 years ago. I was not particularly keen on subscriptions for that exact reason. However, the categories in all markets at this stage have either reached or are reaching a tipping point when it comes to new products. Trial is fundamental within this category at this point in time. So for that reason, we consider subscriptions to be a really valid offer at this point in time. I think we are also developing the subscription piece, whereby it does not necessarily lock out new product trials. So there are ways to manage subscriptions, whereby there is a range of new products being offered to the consumer, subject to their historic usage patterns and the understanding we have on propensity scoring of new products coming through of what they would and wouldn't like. So I feel as though, as we've moved into Subscriptions 2.0 across the group earlier this year and started rolling it out across multiple markets, I feel as though that issue, both because of the conditions in the market and because of how we have developed the tool, is much less of a challenge now versus what it was 4 or 5 years ago.
Perfect. Thank you. That's all for me.
Thank you.
There are no more phone questions at this time. So I hand the conference back to the speakers for any written questions or closing comments.
So. Okay, I see a question coming in regarding AI; let me read the question out, and we will go from there. And major financial and management consulting firms estimate that AI agents will capture between 10% and 25% of US online retail and e-commerce sales by 2030. Is Haypp doing any preparation for this in development? So in summary, absolutely. We definitely envisage that the future of search is going to move much more as time goes by from the traditional Google model, much more into large language models. However, one aspect here of AI agents, which I think is unique to our category, is that I don't expect our category to be one of the first sectors impacted by AI agents. In fact, I consider us to be pretty far down the line, and the main reason for that is the validation of the individual and the youth access compliance within it. I am not. I do not believe any of the AI agents would be prepared to take the risk of buying products on behalf of people who may not be either entitled to buy the product because of age, or may not be entitled to buy the product because of geography or jurisdiction. So I consider the core focal point is on finding and capturing the customer via the large language models, rather than via generative shopping itself. And we've been doing a huge amount of work in this over the past three years. We have dedicated sections of the organization working within it. I think there are a couple of key aspects within this, and you can see this shrinking even more as the LLMs progress. You were at a stage where, if you put a search term into Google, it would give you back 10,000 results. Two and a half years ago, you put a search term into Claude, or actually two and a half years ago, probably more like ChatGPT. It would give you five results. Now it will generally give you two results when it comes to recommending where you go and what these platforms are capable of doing. The traditional search is that they are able to bring in a much broader remit of information when it comes to determining which platforms they should recommend. And this is part of the reason why we have, firstly, been utilizing our underlying data, and we are updating the content and the underlying data on a nightly basis to keep it what we refer to as blink-fresh, ensuring the LLMs remain aware that we are the most prominent player within this space. There are also other aspects of generating our credibility off-site in this space, and this is part of the reason why we share so much of our data with leading academics to get reports written on it; because once we are named within those leading academic reports, that also explains to the LLMs what a credible and leading player we are within the space. We also do the same when it comes to traditional media such as news articles, etc. We are actively getting out there. LLMs are much better at capturing broad, long-tail data here than traditional search. And then lastly, it's back to what we were talking about in the marketing slide, generating brand awareness and having mentions of your brand across a broader range of platforms, including, albeit within a safe environment. Social media tends to support this as well. So absolutely, even if we are not seeing a significant amount of our traffic coming from LLMs at this point in time, there is a strong belief. I have a strong belief that this is the inevitable path that the search industry will evolve toward over the coming years. It is difficult to quantify exactly how many. So we are dedicating a lot of resources to making sure that not only are we at the forefront of this, but that this will further consolidate the channel and hence it will become. We believe this is a winner-takes-all space. I hope that goes some way towards answering the question. Okay. And then did I see there was another phone question?
Yes, there is a new phone question. Can you please help us read the question in? Okay.
Okay. It appears that we no longer have a new phone question. Just check and see if there are any other questions here. So what does that mean regarding Saudi Arabia? It just says, yeah, that's pretty clear. And. Okay.
Just an update on Saudi Arabia.
I think we just have Saudi Arabia marked with a question mark in here. So I guess somebody is asking for an update on Saudi Arabia. We launched in Saudi Arabia at the beginning of the quarter, as expected; with any new market where we have launched, sales start off quite slowly, but they are growing exponentially. There are various aspects of the operating model which we are refining and we continue to refine. Again, it is comparable with the last half-dozen markets which have launched as well. We are very happy with the team and how they are operating at this point in time. The progress they are making is notable, and we look forward to this being a sizable part of the business, but we do not expect it to be a significant contributor imminently. We think this is a long-term strategy that we are on. Perfect. Okay. With that, I'd like to thank everybody for their participation in the call, and I look forward to speaking to you all for our Q4 results. Thank you very much.
Thank you everyone.
Thank you.



















